PA-PMI
14.9.2020 15:02:33 CEST | Business Wire | Press release
Project Management Institute (PMI), the world's leading association for the project management profession, is shining a light on the talents and ideas of the project community during TED@PMI: Action + Impact , a virtual event on 25-26 September 2020. Open to the public, this free event will celebrate a community of doers and the vision, inspiration and mesmerizing awe of turning big ideas into action.
The TED@PMI Talks were sourced directly from the PMI community. More than 600,000 members and 500 employees, as well as more than 330,000 certification holders in China had the chance to submit their ideas. Through a multi-round process, a team of TED coaches, including TED@PMI Curator Sally Kohn, vetted the entries to find the most compelling stories. From the applicant pool, 12 individuals were selected to go through the TED Talk speaker process, where coaches provide one-on-one storytelling guidance, talk development and public speaking training to sharpen and hone ideas and talks.
During the event, the speakers will take the TED@PMI mainstage across two days, but the event is not just about the Talks. Pre-, during and post-event activities make it possible to build community through experience. Start the event with a total body workout or guided meditation with fellow attendees. Before the TED@PMI mainstage session, learn how to brew the perfect cappuccino and craft the best cocktail to enjoy during the event. Unwind after the mainstage session during the virtual DJ dance parties or by diving deeper into the speakers’ stories during speaker panel discussions. Stay connected with other attendees by creating and exchanging virtual business cards.
“These individuals are not just dedicated to telling their story, they’re dedicated to taking action and making an impact,” said Sunil Prashara, President and CEO of PMI. “It’s people like this - those not afraid to turn an idea into reality - who solve our world’s biggest problems.”
The 12 TED@PMI speakers hail from around the world, representing PMI’s global footprint. From trauma and healing, to communication and community, to project management and social change, these speakers tell their boldest and most inspiring stories.
- Chiwuike Amaechi (Lagos, Nigeria): Storytelling as tradition and transformation that connects us all
- Khulan Batkhuyag (Ulaanbaatar, Mongolia): Permanent life-lessons from the nomadic life of Mongolians
- Wale Elegbede (Rochester, N.Y., U.S.): Stop seeing discrimination as “their” problem and see it as “our problem” — all of us
- Kristin Jones (Springfield, Pa., U.S.): How to talk with your kids about sexual assault, without spreading shame
- Betsy Kauffman (Charlotte, N.C., U.S.): My son with autism is really blunt — and we should all be more like him
- Dinae Knox (Chicago, Ill., U.S.): How to turn life’s depleted soil into rich compost
- YeYoon Kim (Singapore): What kindergarteners taught me about the gift of asking for help
- Kathy Mendias (Bonita, Calif., U.S.): The case for crying — a lot
- Billy Samuel Mwape (Lusaka, Zambia): What if we saw kids with special needs not as problems, but projects
- Danielle Torley (Destin, Fla., U.S.): One woman’s journey from losing a family member in a fire to… becoming a fire dancer?!?
- Mounina Tounkara (Nice, France): The immigrant experience of racism and confronting outsider/insider bias
- Jess Woods (Tucson, Ariz., U.S.): Avoiding the prickly cactuses of life — literally and figuratively
The TED@PMI partnership is all about identifying thought-leaders and unearthing the best ideas from the project management community. Every year, the TED Institute works with a group of carefully selected organizations like PMI to identify their best inventors, connectors, and creators.
To register for free today or to learn more about the speakers, visit: TED.PMI.org .
About Project Management Institute (PMI)
Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org
, www.projectmanagement.com
, www.facebook.com/PMInstitute
and on Twitter @PMInstitute
.
About TED
TED is a nonprofit organization devoted to Ideas Worth Spreading, often in the form of short talks delivered by leading thinkers and doers. Many of these talks are given at TED conferences, intimate TED Salons, and thousands of independently organized TEDx events around the world. Videos of these talks are made available, free, on TED.com
and other platforms. Audio versions of TED Talks are published to TED Talks Daily
, available on all podcast platforms.
TED's open and free initiatives for spreading ideas include TED.com , where new TED Talk videos are posted daily; TEDx , which licenses thousands of individuals and groups to host local, self-organized TED-style events around the world; the TED Fellows program, which selects innovators from around the globe to amplify the impact of their remarkable projects and activities; The Audacious Project , which surfaces and funds critical ideas that have the potential to impact millions of lives; TED Translate , which crowdsources the subtitling of TED Talks so that big ideas can spread across languages and borders; and the educational initiative TED-Ed . TED also has a growing library of original podcasts, including The TED Interview with Chris Anderson, WorkLife with Adam Grant , Pindrop and TEDxSHORTS .
Follow TED on Twitter , Facebook , Instagram and LinkedIn .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200914005509/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
